产品中心 / 产品类型 / ELISA试剂盒 / ELISA 抗体对

Rabbit anti-Human IL-5 mAb (CAP) (RM17737)

This standard curve is only for demonstration purposes. A standard curve should be generated for eachassay.

No significant cross-reactivity or interference was observed.

No significant cross-reactivity or interference was observed.

All(3)|
货号: RM17737
促销价:   ¥2100
抗体定制服务咨询

文献引用 (0)

详细信息

产品名称
Rabbit anti-Human IL-5 mAb (CAP)
货号
RM17737
免疫原
Recombinant IL-5 Protein
纯化方式
Affinity purification
同种型
Rabbit IgG
存储溶液
Supplied as a 0.2um filtered solution in PBS with 0.1%Braveds MB-1,PH 7.4.
CrossReactivity
No cross-reactivity in ELISA assay with recombinant
hIL-2、hIL-3、hIL-4、hIL-9、mIL-5、mIL-2、mIL-4、mIL-9、Human GM-CSF、mGM-CSF、rGM-CSF
存储条件
This antibody can be stored at 2℃-8℃ for one monthwithout detectable loss of activity. Antibody products are stable for twelve months fromdate of receipt when stored at -20℃ to -80℃. Preservative-Free.Avoid repeated freeze-thaw cycles.

* This package insert must be read in its entirety before using this product.

应用

Human IL-5 Sanwich ELISA Immunoassay

 Recommended
Concentration
Sample
ELISA Capture1-4ug/mLRabbit anti-Human IL-5 mAb (CAP) (Cat. No.RM17737)
ELISA Detection0.04-0.16ug/mLRabbit anti-Human IL-5 mAb (DET (Cat. No.RM17738)
Standard1.56-100pg/mLRabbit anti-Human IL-5 Protein

背景信息

Interleukin 5 (IL5) is an interleukin produced by type-2 T helper cells and mast cells. IL-5 is a 115-amino acid (in human, 133 in the mouse) -long TH2 cytokine that is part of the hematopoietic family. Unlike other members of this cytokine family (namely interleukin 3 and GM-CSF), this glycoprotein in its active form is a homodimer. Interleukin-5 has long been associated with the cause of several allergic diseases including allergic rhinitis and asthma, wherein a large increase in the number of circulating, airway tissue, and induced sputum eosinophils have been observed. Given the high concordance of eosinophils and, in particular, allergic asthma pathology, it has been widely speculated that eosinophils have an important role in the pathology of this disease. Drugs that target IL-5 are mepolizumab and reslizumab.

>